Blog
RSS FeedPosted by Michael Wonder on 24 Jan 2018
PhRMA launches new consumer-facing Let's Talk About Cost website
24 January 2018 - Today, as part of the Let's Talk About Cost campaign, PhRMA launched LetsTalkAboutCost.org, a national consumer-facing ...
Posted by Michael Wonder on 23 Jan 2018
FDA accepts investigational new drug application and grants fast track status for SOBI003 for the treatment of MPS IIIA
23 January 2018 - Swedish Orphan Biovitrum announces that the FDA has issued a study may proceed letter for the ...
Posted by Michael Wonder on 23 Jan 2018
The one year anniversary of the Oncology Center of Excellence
19 January 2018 - One year ago, 19 January 2017, FDA officially launched the Oncology Center of Excellence to leverage the ...
Posted by Michael Wonder on 23 Jan 2018
Baxter announces U.S. FDA approval of ready-to-use cardiovascular medication bivalirudin
22 January 2018 - First presentation of bivalirudin in frozen, premixed, ready-to-use formulation. ...
Posted by Michael Wonder on 23 Jan 2018
Out-of-pocket spending and premium contributions after implementation of the Affordable Care Act
22 January 2018 - Was implementation of the Affordable Care Act associated with reduced spending on out-of-pocket medical expenses and household ...
Posted by Michael Wonder on 22 Jan 2018
Generic drug firms fall as U.S. threatens to sue for damages
19 January 2018 - U.S. may sue as part of criminal investigation: official. ...
Posted by Michael Wonder on 22 Jan 2018
Five factors driving up the cost of oncology drugs
22 January 2018 - One of the key factors that leads to higher costs with all drugs—not just those for ...
Posted by Michael Wonder on 22 Jan 2018
Trump hasn't attacked drug prices, as he promised he would, during his first year in office
19 January 2018 - President Donald Trump has repeatedly criticised the pharmaceutical industry. ...
Posted by Michael Wonder on 22 Jan 2018
How to prevent drug price shenanigans
21 January 2018 - Last year, Marathon Pharmaceuticals acquired a European muscular dystrophy drug, secured FDA approval, and jacked up ...
Posted by Michael Wonder on 21 Jan 2018
A tale of 2 friends with breast cancer; 1 has coverage for costly drug, the other forced to pay
20 January 2018 - Two women say their cases challenge commonly held belief that B.C. is the gold standard for cancer ...
Posted by Michael Wonder on 20 Jan 2018
U.S. FDA grants priority review for daratumumab in front line multiple myeloma
19 January 2018 - 21 May 2018 PDUFA date. ...
Posted by Michael Wonder on 20 Jan 2018
The FDA should shine more light on drug rejections
19 January 2018 - The status quo helps companies doll up failures, hurting investors and public health. ...
Posted by Michael Wonder on 19 Jan 2018
Aquestive Therapeutics announces U.S. FDA filing acceptance of new drug application for clobazam oral soluble film to treat Lennox-Gastaut syndrome
18 January 2018 - Aquestive Therapeutics today announced that the U.S. FDA has accepted for review the company’s new drug application ...
Posted by Michael Wonder on 19 Jan 2018
Drug maker raises U.S. price of muscular dystrophy treatment
18 January 2018 - Cost of drug Emflaza, which came under scrutiny last year, will go up by 9% for regular ...
Posted by Michael Wonder on 19 Jan 2018
Avion Pharmaceuticals announces approval of first NDA in the oral contraceptive category
18 January 2018 - Avion Pharmaceuticals received approval of its new drug application for the oral contraceptive Balcoltra (levonorgestrel and ...